A method for recovering anticancer drug sensitivity of cancer cells that have acquired anticancer drug resistance

摘要

The present invention relates to a method for restoring cisplatin sensitivity to cancer cells that have acquired resistance to cisplatin, and an RNAi vector that can express an FGF13 gene expression inhibitor, for example, an RNAi substance that targets the FGF13 gene, in the cell. The present invention provides a method for recovering the cisplatin sensitivity of cancer cells that have acquired cisplatin resistance by using a pharmaceutical composition containing as an active ingredient, and an anticancer therapeutic method that suppresses the ability to acquire cisplatin resistance when used in combination with cisplatin. [Selection figure] None